Diabetes Mellitus is a modern epidemics and refractory disease caused by overeating or insulin-related pathogenesis. However, treatment for diabetes mellitus is no easy task. There are many problems facing diabetes mellitus therapy; Insulin or its peptide derivatives need needle injection every day, which lead to treatment inconvenience and burdens for patients; Disease complications, such as cardiovascular symptoms, eye impairment or kidney failure are even fatal for some of patients; Drug toxicities owing to long-term utilization of chemical drugs are equally harmful for patients. In this editorial, we will offer some new ideas for building diabetes mellitus treatment systems, drug design and development pipelines and possible future directions are given and highlighted.
Diabetes Mellitus is an old disease but modern epidemic and also refractory disease caused by overeating or insulin-related pathogenesis. However, treatment for diabetes mellitus is no easy task. There are three major problems facing diabetes mellitus therapy; 1. Insulin or its peptide derivatives need needle injection every day, which lead to treatment burden for patients; 2. Disease complications, such as cardiovascular symptom, eye impairment or kidney failure are even fatal for some of diabetes mellitus patients; 3. Drug toxicities owing to long-term utilization of chemical drugs are equally harmful impacts for many diabetes mellitus patients. In this editorial, we will offer some new ideas for diabetes mellitus treatment and drug design and development pipelines and clinical trials in following topics.
Rethink Of Diabetes Treatment and Drug Development: Da-Yong Lu* and Jin-Yu Che
Last date updated on September, 2024
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi